BRIEF-Biocryst’s Rapivab receives FDA approval for a pediatric indication
September 21, 2017 at 06:22 AM EDT
* Biocryst’s Rapivab (peramivir injection) receives FDA approval for a pediatric indication
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |